Shanghai Aladdin Biochemical TechnologyLtd Second Quarter 2024 Earnings: EPS: CN¥0.10 (vs CN¥0.053 in 2Q 2023)

Simply Wall St · 09/01 00:39

Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥140.0m (up 42% from 2Q 2023).
  • Net income: CN¥30.2m (up 121% from 2Q 2023).
  • Profit margin: 22% (up from 14% in 2Q 2023). The increase in margin was driven by higher revenue.
  • EPS: CN¥0.10 (up from CN¥0.053 in 2Q 2023).
earnings-and-revenue-history
SHSE:688179 Earnings and Revenue History September 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Shanghai Aladdin Biochemical TechnologyLtd Earnings Insights

Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.

Performance of the Chinese Chemicals industry.

The company's shares are up 14% from a week ago.

Risk Analysis

Before you take the next step you should know about the 1 warning sign for Shanghai Aladdin Biochemical TechnologyLtd that we have uncovered.